Introduction {#S1}
============

Antimicrobial resistance is an ongoing severe public and animal health problem ([@B27]). This issue occurs not only in pathogenic bacteria but also in non-pathogenic bacteria. The emergence of multidrug-resistant bacteria (MDR) has increased in the last decade and has caused public concerns around the world ([@B10]). Many studies have been reported that in Brazil, about 71.0% of the *E. coli* isolates from commercial chicken carcasses were MDR ([@B20]); in Italy, 66.9% of the *E. coli* isolates from chicken meat were MDR ([@B7]); in Egypt, 100% of the *E. coli* isolates from avian source were MDR ([@B4]), which demonstrated the high antimicrobial resistance. The addition of extensive subtherapeutic doses of antibiotics in animal feed is a very important reason for the rapid dissemination of antibiotic-resistant bacteria ([@B12]).

Polymyxins are used to treat food-producing animals and have been considered the last resort antibiotics for the rapidly increasing MDR gram-negative pathogens, especially carbapenem-resistant *Enterobacteriaceae* ([@B26]; [@B24]; [@B14]). However, polymyxin use in animals and humans has promoted the selection and spread of *mcr*-1 drug-resistant strains ([@B31]). Since *mcr*-1 was discovered in food, animal and human isolates from Southern China, it has already spread to over 40 countries, implying that it played a prevalent role in the transferability of polymyxin resistance ([@B32]; [@B19]). In addition, *mcr*-1 positive plasmids could coexist with other resistance genes, notably ESBL genes; this has probably led to the emergence of pan-drug resistant strains and treatment failure ([@B9]).

It has been reported that *mcr*-1 was restricted mainly to the Enterobacteriaceae, including *E. coli* ([@B25]). *E. coli* is a common inhabitant of the vertebrate intestinal tract and warm-blooded animals ([@B33]). Moreover, avian-origin *E. coli* might hold zoonotic potential to cause human infections ([@B21]).

China is one of the largest producers of chickens, especially in Shandong Province. In 2018, 1.65 billion commercial broilers were produced in Shandong Province, accounting for 41.2% of the country. An epidemiological survey of *E. coli* isolates from chickens from the early 1970s to 2014 suggested that the carriage rate of *mcr*-1 in China increased from 5.2% in 2009 to 30.0% in 2014 ([@B29]). However, in recent years, few studies have been performed on the prevalence and characteristics of avian-origin *mcr-1*-harboring *E. coli* in Shandong Province. Here, we aimed to determine the occurrence of the *mcr*-1-harboring *E. coli* isolated from poultry and their resistance profile between 2017 and 2018 in Shandong Province.

Materials and Methods {#S2}
=====================

Ethics Statement {#S2.SS1}
----------------

All procedures were approved by the Animal Care and Use Committee of Shandong Academy of Agricultural Sciences (SAAS-2019-021).

Samples and Bacteria Isolation {#S2.SS2}
------------------------------

From August 2017 to May 2018, 722 rectal swabs were collected from 8 large intensive poultry farms (farms 1-8) located in Weifang, Dezhou, Yantai, Qingdao, and Liaocheng regions in Shandong Province. The samples were independently collected from individual animals. The stock of poultry per farm was more than 200,000 heads. All the samples were transported in an ice box to our laboratory within 6 h for further analysis.

Each swab sample was inoculated in peptone water and cultured at 37°C for 24 h. A loop-full from incubated broth culture was streaked onto MacConkey's agar and EMB plates. After incubation at 37°C for 24 h, suspected colonies were chosen by microscopical examination and further biochemical identification using the API 20E system (Sysmex bioMerieux, Tokyo, Japan). A total of 668 non-duplicate *E. coli* isolates were collected, and all of them were stored in Tryptic Soy broth plus glycerol (20%) at −20°C until further analysis ([Table 1](#T1){ref-type="table"}).

###### 

The prevalence of *mcr*-1 positive *E. coli* isolates from poultry farms.

  **Farms**   **Locations**   **No. of isolates**   **No. of *mcr*-1 positive isolates**
  ----------- --------------- --------------------- --------------------------------------
  Farm 1      Weifang         62                    4(6.5%)
  Farm 2      Dezhou          72                    5(6.9%)
  Farm 3      Yantai          124                   42(33.9%)
  Farm 4      Qingdao         62                    1(1.6%)
  Farm 5      Qingdao         60                    1(1.7%)
  Farm 6      Yantai          102                   42(41.2%)
  Farm 7      Yantai          100                   6(6.0%)
  Farm 8      Liaocheng       86                    1(1.2%)
  Total                       668                   102(15.3%)

*mcr*-1 Gene Detection {#S2.SS3}
----------------------

All *E. coli* isolates were grown in Tryptic Soy broth with shaking overnight at 37°C. According to the manufacturer's protocol, genomic DNA was extracted with a TIANamp Bacteria DNA Kit (Tiangen, Beijing, China). All isolates were screened for the *mcr*-1 gene by polymerase chain reaction (PCR) using primers and conditions as previously described ([@B19]). The PCR amplicons were purified and subsequently sequenced (Sangon, Beijing, China), and the obtained DNA sequences were compared with those in GenBank using Basic Local Alignment Search Tool (BLAST).

Antimicrobial Susceptibility Test {#S2.SS4}
---------------------------------

Antimicrobial susceptibility testing was performed on all *E. coli* isolates for 10 antimicrobial agents commonly used in farms including amoxicillin/clavulanic acid (AC), amoxicillin (AMO), ampicillin (AMP), ceftiofur (CEF), enrofloxacin (ENR), neomycin (NEO), doxycycline (DOX), florfenicol (FLO), gentamicin (GEN), and polymyxin (PB) by the agar dilution method recommended by the Clinical and Laboratory Standards Institute ([@B2]); the susceptibility to colistin was interpreted according to the EUCAST guidelines^[1](#footnote1){ref-type="fn"}^. The *E. coli* isolate ATCC 25922 was used as a quality control in this study.

Detection of Antimicrobial Resistance Genes {#S2.SS5}
-------------------------------------------

*mcr*-1 positive isolates were characterized for extended-spectrum β-lactamase genes (ESBL) (*bla*~TEM~, *bla*~CTX--M~, *bla*~OXA~, *bla*~SHV~ and *bla*~PSE~) and plasmid-mediated quinolone resistance genes (PMQR) \[*aac(6)-Ib-cr*, *qnrA*, *qnrB*, *qnrC*, *qnrD*, *qepA*, *oqxA*, and *oqxB*\] by PCR using previously reported primers and conditions ([@B1]; [@B16]). PCR products were visualized on 1.5% agarose gels, and the images were captured using image Capture Systems (Tanon-2500, Shanghai, China).

MLST {#S2.SS6}
----

The *mcr*-1 positive isolates were characterized using the MLST scheme. MLST analysis was carried out by sequencing fragments of seven housekeeping genes (*adk*, *fumC*, *gyrB*, *icd*, *mdh*, *purA*, and *recA*) as described online^[2](#footnote2){ref-type="fn"}^. The PCR amplicons were purified and subsequently sequenced (Sangon, Beijing, China), and the alleles and sequence types (STs) were assigned according to the MLST database^[3](#footnote3){ref-type="fn"}^. A minimum spanning tree was created using BioNumerics software 6.5 (Applied Maths, Kortrijk, Belgium) to analyze the distribution of STs.

Statistical Analysis {#S2.SS7}
--------------------

Statistical comparisons of resistance to the 10 antimicrobial agents between *mcr*-1 positive isolates and *mcr*-1 negative isolates were analyzed using Fisher's exact test or the chi-square test, which were performed using GraphPad INSTAT (GraphPad Software, Inc., United States). A value of *P* \< 0.01 was considered significant.

Results {#S3}
=======

Prevalence of *mcr*-1 in Poultry Farms {#S3.SS1}
--------------------------------------

Over the course of the study, 668 *E. coli* isolates were collected, and 102 (15.3%) of these were found to harbor the *mcr*-1 gene. The 102 *mcr*-1 positive isolates originated from poultry of farm 1 (*n* = 4), farm 2 (*n* = 5), farm 3 (*n* = 42), farm 4 (*n* = 1), farm 5 (*n* = 1), farm 6 (*n* = 42), farm 7 (*n* = 6), and farm 8 (*n* = 1). The prevalence of *mcr*-1 was 15.3% (102/668) ([Table 1](#T1){ref-type="table"}).

Antimicrobial Susceptibility Test {#S3.SS2}
---------------------------------

Of the 102 *mcr*-1 positive isolates, resistance to AMP was common (100/102, 98.0%), followed by resistance to AMO (99/102, 97.1%) and FLO (97/102, 95.1%), and a low level of resistance was found for AC (24/102, 23.5%). In addition, the 102 *mcr*-1 positive isolates showed higher resistance to CEF, ENR, GEN and PB than the *mcr*-1 negative *E. coli* isolates ([Table 2](#T2){ref-type="table"}).

###### 

The *mcr*-1 positive *E. coli* and the *mcr*-1 negative *E. coli* isolatesfrom poultry farms.

  ***Antimicrobials***         **No. of isolates**   
  ---------------------- ----- --------------------- ----------
  AC                     24    90                    0.08
  AMO                    99    506                   0.02
  AMP                    100   509                   0.02
  CEF                    86    233                   \<0.0001
  ENR                    81    326                   \<0.0001
  NEO                    74    337                   0.02
  DOX                    91    527                   0.45
  FLO                    97    548                   0.56
  GEN                    66    165                   \<0.0001
  PB                     75    54                    \<0.0001

Factors impacting mating in

P. infestans

Factors impacting mating in

P. infestans

Detection of Antimicrobial Resistance Genes {#S3.SS3}
-------------------------------------------

Among the 102 *mcr*-1 positive isolates, five ESBL genes were detected, all the isolates carried *bla*~TEM~ (102/102, 100%), followed by *bla*~CTX--M~ (90/102, 88.2%), *bla*~PSE~ (30/102, 29.4%), *bla*~OXA~ (16/102, 15.7%) and *bla*~SHV~ (4/102, 3.9%). Four PMQR genes were detected; *aac(6)-Ib-cr* (40/102, 39.2%) was the most commonly isolated PMQR gene, followed by *qnrA* (10/102, 9.8%), *qnrB* (4/102, 3.9%), and *qnrC* (1/102, 0.9%), and no other PMQR genes were detected ([Table 3](#T3){ref-type="table"}).

###### 

Resistance phenotype, STs and resistance genes in the *mcr*-1 positive *E. coli* isolated from poultry farms.

  **Farms**   **NO.**   **Resistance phenotype**                **ST**   **Resistance genes**
  ----------- --------- --------------------------------------- -------- -----------------------------------------------------------
  Farm 1      1-1       AC-AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB   1251     *bla*~TEM~, *bla*~CTX--M~
              1-2       AC-AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB   219      *bla*~*TEM*,~ *aac(6)-Ib-cr*
              1-3       AMO-AMP-CEF-DOX-ENR-FLO-GEN-PB          4710     *bla*~TEM~, *bla*~CTX--M~
              1-4       AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      10       *bla*~TEM~, *bla*~PSE,~ *aac(6)-Ib-cr*
  Farm 2      2-1       AC-AMO-AMP-DOX-ENR-FLO-GEN              4477     *bla*~TEM~, *bla*~SHV~, *bla*~CTX--M~
              2-2       AC-AMO-AMP-DOX-FLO                      4477     *bla*~TEM~, *bla*~PSE,~ *bla*~SHV~, *bla*~CTX--M~
              2-3       AC-AMO-DOX-NEO                          4477     *bla*~TEM~, *bla*~CTX--M~
              2-4       AC-AMP-DOX-FLO                          4477     *bla*~TEM~
              2-5       AC-AMP-DOX-ENR-FLO                      4477     *bla*~*TEM*,~*aac(6)-Ib-cr*
  Farm 3      3-1       AMO-AMP-CEF-DOX-FLO-GEN-NEO-PB          93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-2       AMO-AMP-CEF-DOX-ENR-FLO                 93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ a*ac(6)-Ib-cr*
              3-3       AMO-AMP-CEF-DOX-ENR-FLO                 93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-4       AMO-AMP-CEF-DOX-ENR -GEN-NEO-PB         93       *bla*~TEM~, *bla*~PSE,~ *aac(6)-Ib-cr*
              3-5       AMO-AMP-CEF-DOX-ENR-FLO                 93       *bla*~TEM~, *bla*~PSE,~ *aac(6)-Ib-cr*
              3-6       AMO-AMP-CEF-DOX -FLO-GEN-NEO-PB         93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M~
              3-7       AMO-AMP-CEF-DOX -FLO-GEN-NEO-PB         93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-8       AMO-AMP-CEF-DOX -FLO-GEN-NEO-PB         423      *bla*~TEM~, *bla*~CTX--M~
              3-9       AMO-AMP-CEF-DOX-GEN-NEO-PB              93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-10      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO         93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-11      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      10       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M~
              3-12      AMO-AMP-CEF-DOX-ENR-FLO                 95       *bla*~*TEM*,~ *aac(6)-Ib-cr*
              3-13      AMO-AMP-CEF-DOX -FLO-GEN-NEO-PB         93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-14      AMO-AMP-CEF-DOX-ENR-FLO-PB              93       *bla*~*TEM*,~ *aac(6)-Ib-cr*
              3-15      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO         93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-16      AMO-AMP-CEF-DOX-ENR-FLO                 95       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-17      AMO-AMP-CEF -ENR-FLO                    224      *bla*~TEM~, *bla*~CTX--M~
              3-18      AC-AMO-AMP-CEF-DOX -FLO-GEN-NEO-PB      10       *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-19      AC-AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO      93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-20      AC-AMO-AMP-CEF-DOX -FLO-GEN-NEO-PB      10       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M~
              3-21      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO         93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-22      AMO-AMP-GEN                             10       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M~
              3-23      AMO-AMP -DOX-ENR-FLO-GEN-NEO            168      *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-24      AC-AMO-AMP-CEF-DOX-ENR-FLO              93       *bla*~TEM~, *bla*~PSE,~ *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-25      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO         93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-26      AC-AMO-AMP-CEF-DOX-FLO-GEN-NEO-PB       93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-27      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO         95       *bla*~TEM~, *bla*~PSE,~ *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-28      AMO-AMP-CEF-DOX-ENR-FLO-PB              93       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-29      AMO-AMP-CEF-DOX -FLO -NEO               48       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M~
              3-30      AMO-AMP-CEF-DOX-ENR-FLO-PB              1011     *bla*~TEM~, *bla*~CTX--M,~*aac(6)-Ib-cr*
              3-31      AC-AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB   48       *bla*~TEM~, *bla*~CTX--M~
              3-32      AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          69       *bla*~TEM~, *bla*~CTX--M~
              3-33      AC-AMO-AMP-CEF-DOX -FLO-GEN-NEO-PB      101      *bla*~TEM~, *bla*~CTX--M,~ *qnrC*
              3-34      AMO-AMP-CEF-DOX-ENR-FLO                 38       *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-35      AC-AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB   43       *bla*~TEM~, *bla*~CTX--M,~ *qnrB*
              3-36      AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          43       *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-37      AMO-AMP-CEF-DOX-ENR-FLO -NEO-PB         602      *bla*~TEM~, *bla*~CTX--M~
              3-38      AC-AMO-AMP-CEF-DOX-ENR-FLO-GEN -PB      93       *bla*~TEM~, *bla*~CTX--M~
              3-39      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO         48       *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              3-40      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      4969     *bla*~TEM~, *bla*~CTX--M~
              3-41      AC-AMO-AMP-CEF-DOX-ENR-FLO              206      *bla*~TEM~, *bla*~CTX--M~
              3-42      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      7584     *bla*~TEM~, *bla*~CTX--M~
  Farm 4      4-1       AMO-AMP-DOX -FLO-GEN-NEO                48       *bla*~TEM~
  Farm 5      5-1       AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          359      *bla*~TEM~, *bla*~CTX--M~
  Farm 6      6-1       AMO-AMP-DOX-ENR-FLO-NEO                 4969     *bla*~TEM~
              6-2       AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      1011     *bla*~TEM~, *bla*~CTX--M,~ *qnrA*
              6-3       AC-AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB   8900     *bla*~TEM~, *bla*~CTX--M~
              6-4       AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      156      *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*, *qnrA*
              6-5       AMO-AMP-CEF-DOX-FLO-GEN-NEO-PB          156      *bla*~TEM~, *bla*~CTX--M~
              6-6       AMO-AMP-CEF-DOX-FLO-GEN-NEO-PB          271      *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M,~ *qnrA, qnrB*
              6-7       AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          359      *bla*~TEM~, *bla*~CTX--M~
              6-8       AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          1011     *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*, *qnrA*
              6-9       AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      1286     *bla*~TEM~, *bla*~CTX--M~
              6-10      AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          359      *bla*~TEM~, *bla*~CTX--M~
              6-11      AC-AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB       271      *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*, *qnrA*, *qnrB*
              6-12      AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          359      *bla*~TEM~, *bla*~CTX--M~
              6-13      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      1011     *bla*~TEM~, *bla*~CTX--M,~ *qnrA*
              6-14      AMO-AMP-CEF-DOX-ENR-FLO-GEN             359      *bla*~TEM~, *bla*~CTX--M~
              6-15      AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          359      *bla*~TEM~, *bla*~CTX--M~
              6-16      AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          101      *bla*~TEM~, *bla*~CTX--M~
              6-17      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      359      *bla*~TEM~, *bla*~CTX--M,~ *qnrA*
              6-18      AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB          1286     *bla*~TEM~, *bla*~CTX--M,~ *qnrB*
              6-19      AMO-AMP-CEF-ENR-FLO-GEN-NEO-PB          1011     *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*, *qnrA*
              6-20      AC-AMO-AMP-CEF -ENR-FLO-NEO-PB          4753     *bla*~TEM~, *bla*~CTX--M,~ *qnrA*
              6-21      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      4204     *bla*~TEM~, *bla*~CTX--M~
              6-22      AMO-AMP-CEF-DOX-ENR-FLO-PB              354      *bla*~TEM~, *bla*~CTX--M~
              6-23      AMO-AMP-CEF-ENR-FLO-GEN-NEO-PB          1011     *bla*~TEM~, *bla*~CTX--M~
              6-24      AMO-AMP-CEF-FLO-GEN-NEO-PB              189      *bla*~TEM~, *bla*~CTX--M~
              6-25      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      1266     *bla*~TEM~, *bla*~CTX--M,~*aac(6)-Ib-cr*
              6-26      AC-AMO-AMP-CEF-DOX-ENR-FLO-PB           48       *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              6-27      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      101      *bla*~TEM~, *bla*~CTX--M,~ *bla*~*OXA*,~ *aac(6)-Ib-cr*
              6-28      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      156      *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M~
              6-29      AC-AMO-AMP-CEF-DOX-ENR-FLO-NEO-PB       1011     *bla*~TEM~, *bla*~PSE,~ *bla*~CTX--M,~ *aac(6)-Ib-cr*
              6-30      AMO-AMP-CEF-ENR-FLO-GEN-PB              48       *bla*~TEM~, *bla*~CTX--M~
              6-31      AMO-AMP-CEF-DOX-ENR-FLO-GEN-PB          189      *bla*~TEM~, *bla*~CTX--M~
              6-32      AMO-AMP-DOX-ENR-FLO-GEN-PB              2732     *bla*~TEM~
              6-33      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      156      *bla*~TEM~
              6-34      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      4129     *bla*~TEM~, *bla*~CTX--M~
              6-35      AC-AMO-AMP-DOX-ENR-FLO-GEN-NEO-PB       648      *bla*~TEM~, *bla*~CTX--M~
              6-36      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      617      *bla*~TEM~, *bla*~CTX--M~
              6-37      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      48       *bla*~TEM~, *bla*~CTX--M~
              6-38      AMO-AMP-DOX-ENR-FLO-GEN-NEO-PB          7108     *bla*~TEM~, *bla*~CTX--M~
              6-39      AMO-AMP-CEF-ENR-FLO-GEN-NEO-PB          189      *bla*~TEM~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
              6-40      AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      7108     *bla*~TEM~, *bla*~CTX--M~
              6-41      AMO-AMP-DOX-FLO-GEN-NEO-PB              48       *bla*~TEM~
              6-42      AMO-AMP-CEF -FLO-GEN-NEO-PB             189      *bla*~TEM~, *bla*~CTX--M~
  Farm 7      7-1       ENR-PB                                  224      *bla*~TEM~, *bla*~CTX--M~
              7-2       AMO-AMP-CEF-ENR-FLO-GEN-NEO-PB          224      *bla*~TEM~, *bla*~CTX--M~
              7-3       AMO-AMP-DOX-ENR-FLO-PB                  2847     *bla*~TEM~, *bla*~CTX--M,~ *qnrA*
              7-4       AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB      117      *bla*~TEM~, *bla*~CTX--M~
              7-5       AMO-AMP-CEF-DOX-ENR-FLO-GEN -PB         117      *bla*~*TEM*,~ *aac(6)-Ib-cr*
              7-6       AC-AMO-AMP-CEF-DOX-ENR-FLO-GEN-NEO-PB   297      *bla*~TEM~, *bla*~SHV~, *bla*~CTX--M,~ *aac(6)-Ib-cr*
  Farm 8      8-1       AMO-AMP-DOX-ENR-FLO-GEN-NEO-PB          48       *bla*~*TEM*,~ *bla*~SHV~, *bla*~CTX--M~

MLST {#S3.SS4}
----

Among the 102 *mcr*-1 positive isolates, 38 different kinds of STs were identified. The dominant ST was ST93 (19/102, 18.6%), followed by ST48 (9/102, 8.8%), ST1011 (7/102, 6.9%) and ST359 (7/102, 6.9%). Of note, 73.7% (14/19) of ST93 isolates carried *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M~, *aac(6)-Ib-cr*. BioNumerics software version 6.5 was used to generate a minimum-spanning tree based on all the sources of STs. As a result, ST2732 and ST4129 belonged to one clone complex, ST2847 and ST4969 belonged to one clone complex, and ST7108, ST48, ST1286, ST10, ST43, ST4204, and ST8900 belonged to one complex ([Figure 1](#F1){ref-type="fig"}).

![Minimum-spanning tree analysis of the 102 *mcr*-1 positive isolates. Each circle represents one ST, and the area of the circle corresponds to the number of isolates, the shadow region indicates that ST2732 and ST4129 belonged to one clone complex, ST2847 and ST4969 belonged to one clone complex, ST7108, ST48, ST1286, ST10, ST43, ST4204, and ST8900 belonged to one complex.](fmicb-11-00255-g001){#F1}

Discussion {#S4}
==========

The colibacillosis of poultry caused by *E. coli* is the most common infectious disease worldwide ([@B22]; [@B18]). The growing selective pressure of antimicrobial treatments may contribute to the rapid spread of antimicrobial resistance genes ([@B8]). In this study, we detected the *mcr*-1 gene in 102 (15.3%) *E. coli* isolates. The prevalence of *mcr*-1 (15.3%) in this study was higher than that in Japan; 9,303 *E. coli* were isolated from healthy animals between 2000 and 2014, and 39 (0.4%) of them were carried the *mcr*-1 gene ([@B13]). In Europe, 10,206 *E. coli* were isolated from cattle, pigs and chickens between 2008 and 2014, 68 (0.7%) of which carried the *mcr*-1 gene ([@B6]). Such a high prevalence may be due to the selection of the farms tested and the methodology used. In addition, the different prevalence of *mcr*-1 in each farm might be associated with the different use of drugs and management in this study. Of note, in the same region, the prevalence of *mcr*-1 from farm 3 and farm 6 was higher than farm 7, this probably due to the different dosage of the polymyxin used in the farms.

In the current study, we noticed a high rate of resistance to AMP, AMO, and FLO in the *mcr*-1 positive isolates similar to a report in Eastern China from 2015 to 2017 ([@B36]), suggesting that these drugs may have been widely used in poultry farming. Most of the *mcr*-1 positive isolates showed susceptibility to AC, which was associated with the infrequent use of this drug, and the result was consistent with other reports ([@B3]). In addition, the *mcr*-1 positive isolates showed higher resistance to PB than the *mcr*-1 negative *E. coli* isolates in this study, which suggested that there was a close positive correlation between the resistance phenotypes and genotypes of the *mcr*-1 positive isolates. This result is consistent with other reports ([@B11]; [@B30]; [@B36]).

Extended-spectrum β-lactamase genes and *mcr*-1 phosphoethanolamine transferase enzymes have been identified as the main plasmid-mediated mechanisms of resistance to third-generation cephalosporins and colistin, respectively, and are currently considered a major concern both in human and veterinary medicine. Many studies of *E. coli* strains, most of which were isolated from animals, have demonstrated the presence of the *mcr*-1 gene together with ESBL genes ([@B28]). In this study, all the *mcr*-1 positive isolates carried *bla*~TEM~, which was consistent with the result that 98.0% of the *mcr*-1 positive isolates were resistant to AMP. CTX-M-producing enterobacteria are widespread among human populations, but an increasing number of reports have described their presence in food animals and their environment ([@B17]; [@B5]; [@B15]). In the present study, 88.2% of the *mcr*-1 positive isolates carried *bla*~CTX--M~, which was similar to a previous study in which more than half of the chicken-origin *mcr*-1 positive strains presented the coexistence of the *mcr*-1 and *bla*~CTX--M~ genes ([@B34]), but higher than the 43.1% *mc*r-1 positive isolates carrying *bla*~CTX--M~ genes. The increasing prevalence and dissemination of co-carriage of ESBL genes in *mcr*-1 positive *E. coli* isolates found in our study suggested that it may add challenge to the global problem of difficult to treat and untreatable infections.

Quinolones are one of the main choices for the treatment of colibacillosis that occurs in humans and animals ([@B23]). Thus, quinolone resistance is a public health issue that can lead to treatment failures and the use of alternative agents with greater side effects. In this study, *aac(6)-Ib-cr* was the most commonly isolated PMQR gene among the *mcr*-1 positive isolates, which was consistent with a previous report ([@B35]). However, it was different from a report in Argentina that did not detect *aac(6)-Ib-cr* from *mcr*-1 positive isolates from poultry, and the most prevalent PMQR gene was *qnrB* ([@B3]). In addition, most isolates carried *aac(6)-Ib-cr*, which confer resistance to enrofloxacin and gentamicin. In this study, we also found the *qnrA*, *qnrB*, and *qnrC* genes. According to the results of this study, we suggest that *E. coli* from poultry could be a reservoir not only for the *mcr-1* gene but also for PMQR and ESBL genes.

In the current study, the MLST results revealed 38 distinct STs, which showed abundant diversity among *mcr*-1 positive isolates from different geographic locations. Notably, ST93 was the most common. It was different from that of previous studies that identified 40 distinct STs in 102 *mcr*-1 positive isolates, and ST48 was the most common ([@B34]). In addition, 73.7% of ST93 isolates carried *bla*~TEM~, *bla*~PSE~, *bla*~CTX--M~, *aac(6)-Ib-cr*, which were all from the same farm, indicating that the majority of the *mcr*-1 isolates from the same farm were probably clonal.

Conclusion {#S5}
==========

Our results showed that the *mcr*-1 gene was present at a high prevalence in Shandong Province, and poultry can be an important reservoir of *mcr*-1 carrying *E. coli* strains. The wide range of phenotypic resistance to antibiotics in veterinary medicine was identified, and the high rate of antibiotic resistance gene-positive isolates detected suggest that defining avian-source *mcr*-1 positive isolates is critical for public health purposes.
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